Results 191 to 200 of about 11,703 (213)

Oncolytic virotherapy of gynecologic malignancies

Gynecologic Oncology, 2011
Gynecologic cancer is still the third leading cause of cancer death among women in the US. Therapeutics employing novel mechanisms of action are therefore urgently needed. Oncolytic viruses (OVs) selectively infecting and replicating in cancer cells have recently attracted considerable interest as promising anti-cancer agents.
Andreas D, Hartkopf, Tanja, Fehm, Diethelm, Wallwiener, Ulrich, Lauer   +3 more
openaire   +2 more sources

Systemic virotherapy for multiple myeloma

Expert Opinion on Biological Therapy, 2017
The multiple myeloma (MM) treatment scenario has changed considerably over the past few years. Several novel targeted therapies are currently under consideration including oncolytic virotherapy. Areas covered: This review provides an analysis of the mechanisms of action of virotherapy, and summarizes the preclinical and clinical studies of systemic ...
Stefania, Oliva, Manuela, Gambella, Mario, Boccadoro, Sara, Bringhen   +3 more
openaire   +2 more sources

Gene Therapy and Virotherapy of Gliomas

2018
Despite many recent advances in the management of gliomas, such as aggressive surgical resection, chemoradiotherapy, antiangiogenic therapy, and molecular targeted therapy, the survival of patients with high-grade neoplasms remains dismal. Gene therapy and oncolytic virotherapy have emerged as highly promising strategies for treatment of malignant ...
Julius W, Kim, Alan L, Chang, J Robert, Kane, Jacob S, Young, Jian, Qiao, Maciej S, Lesniak   +5 more
openaire   +2 more sources

Virotherapy

2023
Sathiamoorthi Thangavelu, Saikishore Ramanthan, Palanivel Velmurugan, Ranjithkumar Dhandapani   +3 more
openaire   +1 more source

Virotherapy in cancer.

Iranian journal of cancer prevention, 2014
New cancer therapies with novel mechanisms and functions are needed to treatpatients with different cancers. Virotherapy is a good scenario for such treatment. The advantages of virotherapy include the potential lack of cross resistance with standard therapies and the ability to cause tumor destruction by numerous mechanisms.
openaire   +1 more source

Virotherapy

2008
Zeng B. Zhu, Bruce F. Smith, Gene P. Siegal, David T. Curiel   +3 more
openaire   +1 more source

A systematic analysis on the clinical safety and efficacy of onco-virotherapy

Molecular Therapy - Oncolytics, 2021
Darshak K Bhatt, Lieske Wekema, Luciana Rodrigues Carvalho Barros   +2 more
exaly  

Optimizing oncolytic virotherapy in cancer treatment

Nature reviews. Drug discovery, 2019
K. Harrington, Daniel J. Freeman, B. Kelly, J. Harper, J. Soria   +4 more
semanticscholar   +1 more source

The Multifaceted Role of Macrophages in Oncolytic Virotherapy

Viruses, 2021
Laura Hofman, Sean E Lawler, Martine L M Lamfers   +2 more
exaly  

Oncolytic Virotherapy: A Contest between Apples and Oranges

Molecular Therapy, 2017
Stephen J Russell, Kah-Whye Peng
exaly